Mr Jeffrey Fred Davang, CRNA | |
1501 E Mockingbird Ln, 101, Victoria, TX 77904-2155 | |
(361) 573-2481 | |
(361) 576-2434 |
Full Name | Mr Jeffrey Fred Davang |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1501 E Mockingbird Ln, Victoria, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003806464 | NPI | - | NPPES |
83842U | Other | TX | BLUE CROSS/BLUE SHIELD |
052983 | Other | TX | RECERTIFICATION |
151044802 | Medicaid | TX | |
P00090293 | Other | TX | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 642422 (Texas) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | 642422 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Jeffrey Fred Davang, CRNA 3719 County Road 131, Wharton, TX 77488-8535 Ph: (713) 252-5200 | Mr Jeffrey Fred Davang, CRNA 1501 E Mockingbird Ln, 101, Victoria, TX 77904-2155 Ph: (361) 573-2481 |
News Archive
No one knows what makes a mild dengue viral infection morph into a severe and sometimes deadly dengue hemorrhagic fever/dengue shock syndrome.
A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer.
Dr. Sheela Basrur, Ontario's Chief Medical Officer of Health and Dr. Allen Heimann, Medical Officer of Health for Windsor-Essex County confirmed Ontario's first probable human case of West Nile virus in the Windsor-Essex area.
Age-related macular degeneration (AMD) is the principal cause of vision loss in industrialised countries, with nearly 20 million people affected in Europe in 2020. Although identified as a risk factor, until now it was impossible to evaluate retinal omega-3 fatty acid deficits.
Arena Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) trial.
› Verified 7 days ago